Cite
HARVARD Citation
Nakamura, I. et al. (2021). Real-World Evidence for Long-Term Safety and Effectiveness of Ipragliflozin in Japanese Patients with Type 2 Diabetes Mellitus: final Results of a 3-Year Post-Marketing Surveillance Study (STELLA-LONG TERM). Expert opinion on pharmacotherapy. pp. 373-387. [Online].